Task: Answer the multiple choice question.
Query: Which drug exhibits a -3.370\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CC(C(=O)NCC1(c2ccccc2)CCCC1)N1CCCC1.Cl
b Cc1ccc(C(C)C)c(OCCNCCc2ccccc2)c1.O=C(O)C(=O)O
c CCN(C(=O)CSc1nc(N)cc(N)n1)C1CCS(=O)(=O)C1
Answer: a. CC(C(=O)NCC1(c2ccccc2)CCCC1)N1CCCC1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C(=O)NCC1(c2ccccc2)CCCC1)N1CCCC1.Cl
CC(C(=O)NCC1(c2ccccc2)CCCC1)N1CCCC1.Cl
N-[(1-phenylcyclopentyl)methyl]-2-pyrrolidin-1-ylpropanamide;hydrochloride